About: Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of poly-ADP-ribose polymerase (PARP1/2), which is in a Phase 2 clinical trial for patients with advanced and recurrent ovarian cancer. It is also developing stenoparib with temozolomide, a PARP and WNT inhibitor in combination with a DNA-alkylating chemotherapy agent, which is in a Phase 2 clinical trial for patients with relapsed small cell lung cancer; and stenoparib-DRP, a companion diagnostic product used to select patients for stenoparib treatment. Allarity Therapeutics, Inc. is headquartered in Tarpon Springs, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.98 (-0.13%)
ALLR NASDAQ Allarity Therapeutics Inc
Allarity Therapeutics Inc share price
ALLR price activity
Last Price
$0.980
Change (24hr)
-0.00 USD (-0.13%)
Volume
80.48K
Volume (4w avg)
-
Open
$1.02
Day Range
$0.98 - $1.04
Previous Close
$0.99
Last Trade
07 Oct, 8:00 pm GMT+0
Delayed
07 Oct, 8:00 pm GMT+0
ALLR price performance
Delayed
07 Oct, 8:00 pm GMT+0
ALLR Market Signals